* VistaGen Therapeutics director Douglas J. Williamson filed an initial Form 3 on July 31, 2026.
Back to newsVistaGen files Form 3 as director Douglas J. Williamson reports no beneficial ownershipVVTGN•2026-07-31Director files initial Form 3 VistaGen Therapeutics director Douglas J. Williamson filed an initial Form 3 on July 31, 2026. Related NewsXExxonMobil falls on Q2 profit missXOM•2026-07-31MNasdaq trade halt continues <MCTA.O> reason not available at 09:40 AMMCTA•2026-07-31ZZillow Group Inc <ZG.O>: UBS cuts target price to $50 from $75ZG•2026-07-31SourcesSSVistaGen files Form 3 as director Douglas J. Williamson reports no beneficial ownershipSec
VTGN•VTGN•VTGN•VTGN•
